Fujisawa
Executive Summary
Assuming a 100% ownership of Fujisawa-SmithKline joint venture in U.S., SmithKline will continue selling Cefizox "for the time being." Japan-based SmithKline & Fujisawa KK, formed in 1977, became a 75%-owned subsidiary of SmithKline in 1988. SmithKline will take over full ownership increasing to 100% by March 1993.